Top Stories
-
Columbia researchers have found a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation.
Topic
-
A third of youths in New York City foster care identify as LGBTQAI+, finds a study by Columbia researcher Theo Sandfort. But why so many gender diverse youths end up in foster care is unclear.
Topic
-
A panel discussion held in observance of National Physician Suicide Awareness Day on Sept. 17 highlighted the legacy of Dr. Lorna Breen and the ongoing fight to curb physician suicide.
Topic
-
Dr. Lourival Baptista-Neto speaks about CopeColumbia, where CUIMC employees can access psychological support and other support services.
Topic
Latest News
- July 28, 2016
Dr. Joshua Gordon has been selected as the new director of the National Institute of Mental Health at the NIH.
Topic
- June 16, 2016
In cases of complicated grief, an antidepressant is useful for treating co-occurring depressive symptoms, a new Columbia study has found.
Topic
- June 6, 2016
An international observational study led by Columbia University researchers has uncovered widespread differences in the treatment of patients with common chronic diseases, including type 2 diabetes, hypertension, and depression.
Topic
- May 20, 2016
Researchers from Harvard and Columbia have found that trauma and PTSD symptoms increase the risk of blood clots in women.
Topic
- May 6, 2016
After a manic episode, adults with bipolar disorder are just as likely to experience anxiety as depression, finds a new Columbia Psychiatry study.
Topic
- April 29, 2016
Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy is associated with an increased rate of offspring depression, a new study has found.
Topic
- April 19, 2016
Heavy cannabis use may alter the brain's dopamine system, revealing patterns of addiction commonly seen in other types of illicit drug use.
Topic
- April 11, 2016
Columbia researchers have created a new mouse model of anorexia that may reveal new ways to treat the disorder.
Topic
- April 4, 2016
The biomarker is an important step toward understanding and treating one of the most devastating symptoms of schizophrenia.
Topic
- March 31, 2016
Long-acting naltrexone reduced the risk of relapse among people being treated for opioid dependence, a new study reports.
Topic
